Jean‐François Martini

3.9k citations
56 papers · 2.0k indexed · 2 hit papers · h-index 18
Topics
Lung Cancer Treatments and Mutations (25 papers)Cancer Genomics and Diagnostics (18 papers)Lung Cancer Research Studies (11 papers)
Partner nations
United StatesFranceItaly

In The Last Decade

Jean‐François Martini

52 papers receiving 1.9k citations

Hit Papers

Lorlatinib in non-small-cell lung cancer with ALK or ROS1...201720262020202320172019100200300400

Peers

Jean‐François Martini
Comparison fields: 5 of 89
  • Pulmonary and Respiratory Medicine 1.2k
  • Oncology 1.1k
  • Molecular Biology 765
  • Cancer Research 447
  • Endocrinology, Diabetes and Metabolism 181
Replace Andrew S. Goldstein with:
Andrew S. Goldstein United States
Tobias Zellweger Switzerland
Rosa Caputo Italy
Wolfgang Eicheler Germany
Debyani Chakravarty United States
Arlene Berman United States
Shinji Takeuchi Japan
Shi‐Ming Tu United States
Eeva Kettunen Finland
Karen G. Montgomery Australia
Jean‐François Martini relative to Andrew S. Goldstein United States Andrew S. Goldstein's profile →
Citations per field
00.5×2.6×
Andrew S. Goldstein · 1×
Citations per year

Countries citing papers authored by Jean‐François Martini

Since Specialization
Citations

This map shows the geographic impact of Jean‐François Martini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐François Martini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐François Martini more than expected).

Fields of papers citing papers by Jean‐François Martini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐François Martini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐François Martini. The network helps show where Jean‐François Martini may publish in the future.

Co-authorship network of co-authors of Jean‐François Martini

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐François Martini. A scholar is included among the top collaborators of Jean‐François Martini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐François Martini. Jean‐François Martini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 22
4 26
5 7
6 4
7 2
8 248
9 14
10 14
11 12
12
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trialbreakdown →
487
13 1
14 65
15 1
16 1
17 1
18 93
19 49
20 17

About Jean‐François Martini

Jean‐François Martini is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 56 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Cancer Genomics and Diagnostics (18 papers) and Lung Cancer Research Studies (11 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Cancer Research (447 citations). Jean‐François Martini has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Benjamin Solomon, Alice T. Shaw, Todd M. Bauer, Antonello Abbattista, Benjamin Besse, Jill S. Clancy, Enriqueta Felip, Leonard P. James, Joseph Chen and Holger Thurm. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026